Clinical Research Directory
Browse clinical research sites, groups, and studies.
Neuropsychological Evaluation in Intellectual Disability (ENDI)
Sponsor: Central Hospital, Nancy, France
Summary
The goal of this observational study is to evaluate the acceptability ofpatients with trisomy 21 (T21) to perform the full battery of ENDI neurospychological tests and each of the subsets. In this study, three types of population will be recruted : normotypic volunteers, patients with Intellectual Disability and patients T21carriers. This study is separated into 2 phases : * A the preliminary phase : this phase will be used to evaluate subtest design, ergonomics and understanding of instructions, and to identify any malfunctions. The observations gathered will enable the principal investigator to refine the digital design of the battery in collaboration with the publishing company. In this phase, normotypical volunteers and patients with intellectual disabilities will be recruted to perform ENDI test battery. * A main phase : this phase will enable to answer to the main objective. in this phase, patients with Trisomy 21 aged between 25 and 65 will be recruted to perform ENDI test battery.
Official title: Neuropsychological Evaluation in Intellectual Disability
Key Details
Gender
All
Age Range
25 Years - 65 Years
Study Type
OBSERVATIONAL
Enrollment
40
Start Date
2025-07-01
Completion Date
2026-11-01
Last Updated
2025-07-02
Healthy Volunteers
Yes
Conditions
Interventions
ENDI (Neuropsychological Evaluation in Intellectual Disability)
This neuropsychological battery comprises 15 subtests designed to assess language, memory, attention and executive skills. By analyzing changes in Trisomy 21 patients performance over time, the neuropsychologist can detect early signs of Alzheimer's disease.
Locations (1)
CHRU de Nancy
Vandœuvre-lès-Nancy, Grand Est, France